Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Infusion or QL Block in Gynecologic Oncology Surgery
NCT03658109Phase 1Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- Sep 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (3 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: PACU Post-operative opioid consumption. Started Sep 2019; status: terminated.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03658109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03658109.